Company: GANX
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001558370-25-007747
Chunk: 25

Company: Gain Therapeutics, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 6E
Chunk 25
---
Item 6. Exhibits.

​​​​Incorporated by ReferenceExhibit No.    Exhibit Description    Form    File No.    Exhibit    Filing Date3.1​Amended and Restated Certificate of Incorporation of Gain Therapeutics, Inc.​8-K​001-40237​3.1​3/17/20213.2​Amended and Restated Bylaws of Gain Therapeutics, Inc.​8-K​001-40237​3.2​3/17/202131.1*​Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.​​​​​​​​31.2*​Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.​​​​​​​​32.1†​Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.​​​​​​​​101.INS*​Inline XBRL Instance Document​​​​​​​​101.SCH*​Inline XBRL Taxonomy Extension Schema Document​​​​​​​​101.CAL*​Inline XBRL Taxonomy Extension Calculation Linkbase Document​​​​​​​​101.DEF*​Inline XBRL Taxonomy Extension Definition Linkbase Document​​​​​​​​101.LAB*​Inline XBRL Taxonomy Extension Label Linkbase Document​​​​​​​​101.PRE*​Inline XBRL Taxonomy Extension Presentation Linkbase Document​​​​​​​​104*​Cover Page Interactive Data File (formatted as Inline XBRL and embedded within the iXBRL document)​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

*Filed herewith.

+ Management contract or compensatory plan or arrangement.

† This certification is being furnished solely to accompany this Quarterly Report pursuant to 18 U.S.C Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be